Jamjoom Pharmaceuticals Factory Co. vs Saudi Pharmaceutical Industries & Medical Appliances Corp.
A head-to-head of Jamjoom Pharmaceuticals Factory Co. (4015) and Saudi Pharmaceutical Industries & Medical Appliances Corp. (2070) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
Jamjoom Pharmaceuticals Factory Co.
4015
146.90 SAR
-1.34%
VS
Saudi Pharmaceutical Industries & Medical Appliances Corp.
2070
29.40 SAR
-2.33%
| Metric | 4015 | 2070 |
|---|---|---|
| Market Cap | 11.05B SAR | 3.41B SAR |
| P/E (TTM) | 22.16 | 19.09 |
| Forward P/E | — | 22.97 |
| P/S | 7.25 | 2.07 |
| P/B | 5.95 | 1.93 |
| EV/EBITDA | 20.41 | 14.72 |
| Dividend Yield | 253.00% | 0.01% |
| Profit Margin | 31.16% | 10.85% |
| Gross Margin | 62.56% | 48.78% |
| Operating Margin | 31.82% | 14.52% |
| Revenue Growth (YoY) | +5.21% | -12.58% |
| FCF Yield | 2.33% | 6.92% |
| Debt / Equity | 1.20 | 69.32 |
| Current Ratio | 4.94 | 1.26 |
Which is better: Jamjoom Pharmaceuticals Factory Co. or Saudi Pharmaceutical Industries & Medical Appliances Corp.?
- ✓Larger by market cap: Jamjoom Pharmaceuticals Factory Co.
- ✓Cheaper valuation (lower P/E): Saudi Pharmaceutical Industries & Medical Appliances Corp.
- ✓Higher dividend yield: Jamjoom Pharmaceuticals Factory Co.
- ✓More profitable (net margin): Jamjoom Pharmaceuticals Factory Co.
- ✓Faster revenue growth: Jamjoom Pharmaceuticals Factory Co.
- ✓Higher free-cash-flow yield: Saudi Pharmaceutical Industries & Medical Appliances Corp.
Across 12 available metrics, Jamjoom Pharmaceuticals Factory Co. leads 7–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Jamjoom Pharmaceuticals Factory Co. pageSaudi Pharmaceutical Industries & Medical Appliances Corp. page
Share:
Compare Jamjoom Pharmaceuticals Factory Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.